Argenx
ARGX
#550
Rank
ยฃ27.56 B
Marketcap
ยฃ451.38
Share price
0.99%
Change (1 day)
49.97%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: ยฃ27.56 Billion

As of April 2025 Argenx has a market cap of ยฃ27.56 Billion. This makes Argenx the world's 550th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ27.56 B-7.65%
2024ยฃ29.84 B68.48%
2023ยฃ17.71 B2.25%
2022ยฃ17.32 B27.16%
2021ยฃ13.62 B32.44%
2020ยฃ10.28 B96.11%
2019ยฃ5.24 B89.91%
2018ยฃ2.76 B86.2%
2017ยฃ1.48 B
2014ยฃ93.47 M

End of Day market cap according to different sources

On Apr 24th, 2025 the market cap of Argenx was reported to be:

ยฃ27.53 Billion
by Nasdaq info icon info icon
ยฃ27.90 Billion
by CompaniesMarketCap info icon info icon
ยฃ27.90 Billion
by Yahoo Finance info icon info icon